X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Bal Pharma Ltd.
BSE CODE: 524824   |   NSE CODE: BALPHARMA   |   ISIN CODE : INE083D01012   |   04-Apr-2025 Hrs IST
BSE NSE
Rs. 121.70
12.66 ( 11.61% )
 
Prev Close ( Rs.)
109.04
Open ( Rs.)
114.24
 
High ( Rs.)
128.86
Low ( Rs.)
113.26
 
Volume
118972
Week Avg.Volume
56153
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 122.23
13.89 ( 12.82% )
 
Prev Close ( Rs.)
108.34
Open ( Rs.)
114.95
 
High ( Rs.)
128.74
Low ( Rs.)
113.02
 
Volume
2593991
Week Avg.Volume
529406
 
52 WK High-Low Range(Rs.)
78.06
157.98
Source DateBoard Meeting DateDetails
24-Jan-2025 13-Feb-2025 Quarterly Results
05-Nov-2024 14-Nov-2024 Quarterly Results
30-Aug-2024 09-Sep-2024 Inter alia, to consider and approve:- 1. Allotment of equity shares to the employees of the Company upon conversion of stock options vested on them. 2. To consider expanding its manufacturing presence to meet growing demand for API's. 3.Any other matters incidental to the business operations and ensuing AGM of the Company.
26-Jul-2024 12-Aug-2024 Employees Stock Option Plan & A.G.M. & Quarterly Results
30-Apr-2024 28-May-2024 Audited Results & Final Dividend & Inter alia, to consider and approve:- 1. Recommendation of Dividend, if any, for the financial year ended 31.03.2024. 2.Appoinment of Internal Auditors, Cost Auditors and Secretarial Auditors for f.y ended 31.03.2024.
25-Jan-2024 12-Feb-2024 Quarterly Results
20-Oct-2023 08-Nov-2023 Employees Stock Option Plan & Quarterly Results
01-Aug-2023 11-Aug-2023 Quarterly Results & A.G.M.
16-May-2023 29-May-2023 Audited Results & Final Dividend
27-Jan-2023 06-Feb-2023 Quarterly Results
Page 1 of 12
PREV || NEXT